Effects of powdered whole grapefruit and metoclopramide on the pharmacokinetics of cyclosporine in dogs

American Journal of Veterinary Research

Volumn 72, Issue 5, 2011, Pages 687-693

  Radwanski, Noel E ^a   Cerundolo, Rosario ^a,c   Shofer, Frances S ^a,d   Hanley, Michael J ^b   Court, Michael H ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Veterinary Specialist Centre   (United Kingdom)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METOCLOPRAMIDE; NUTRACEUTICAL; POWDERED WHOLE GRAPEFRUIT; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOG; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DOSE COMPARISON; DRUG HALF LIFE; DRUG POTENTIATION; FEMALE; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; BIOLOGICAL AVAILABILITY; CITRUS PARADISI; CROSS-OVER STUDIES; CYCLOSPORINE; DOGS; DRUG COMBINATIONS; FEMALE; MALE; METOCLOPRAMIDE; PLANT PREPARATIONS; POWDERS; VETERINARY MEDICINE;

CANIS FAMILIARIS; CITRUS X PARADISI;

EID: 79955775242     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.5.687     Document Type: Article

References (34)

1. Barshes NR, Goodpastor SE, Gross JA. Pharmacologic immuno-suppression. Front Biosci 2004;9:411-420.
2. Berth-Jones J, Graham-Brown RAC, Marks R, et al. Long term efficacy and safety of cyclosporine in severe adult atopic dermatitis. Br J Dermatol 1997;136:76-81.
3. Steffan J, Strehlau G, Maurer M, et al. Cyclosporine A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs. J Vet Pharmacol Ther 2004;27:231-238.
4. Guaguére E, Steffan J, Olivry T. Cyclosporine A: a new drug in the field of canine dermatology. Vet Dermatol 2004;15:61-74.
5. Robinson D. Review of the pharmacokinetics, interactions and adverse reaction of cyclosporine in people, dogs and cats. Vet Rec 2003;152:739-748.
6. Daigle JC. More economical use of cyclosporine through combination drug therapy. J Am Hosp Assoc 2002;38:205-208.
7. Atopica [package insert]. Basel, Switzerland: Novartis, 2003.
8. Whalen RD, Tata PNV, Burckart GJ, et al. Species differences in the hepatic and intestinal metabolism of cyclosporine. Xenobiotica 1999;29:3-9.
9. Kolars JC, Awni WM, Merion MR, et al. First-pass metabolism of cyclosporine by the gut. Lancet 1991;338:1488-1490.
10. Watkins PB. The role of cytochromes P-450 in cyclosporine metabolism. J Am Acad Dermatol 1990;23:1301-1311.
11. Albengres E, Tillement JP. Cyclosporine and ketoconazole drug interaction or therapeutic association? Int J Clin Pharmacol Ther Toxicol 1992;30:555-570.
12. Becerra E, Aranguiz E, Pedemonte O, et al. Cardiac transplantation: economizing cyclosporine A by including ketoconazole in the immunosuppressive schedule[in Spanish]. Rev Med Chil 1991;19:1038-1042.
13. Garcia R, Marin C, Herrera J, et al. Usefulness of ketoconazole combined with cyclosporine in renal transplantation. Invest Clin 1991;32:115-121.
14. Dahlinger J, Gregory C, Bea J. Effect of ketoconazole on cyclosporine in healthy dogs. Vet Surg 1998;27:64-68.
15. Mouatt JG. Cyclosporine and ketoconazole interaction for treatment of perianal fistula in the dog. Aust Vet J 2002; 80:207-211.
16. Plumb DC. Ketoconazole. In: Veterinary drug handbook. 5th ed. Ames, Iowa: Blackwell Publishing, 2005;443-446.
17. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after the administration with grapefruit juice. Clin Pharmacol Ther 1995;57:485-491.
18. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, et al. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP 3A4 concentrations and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos 1997;11:1228-1233.
19. Ku YM, Min DI, Flanigan M. Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: does formulation differences matter? J Clin Pharmacol 1998;38:959-965.
20. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P-450 3A4 inhibition. Clin Pharmacokinet 2000;38:41-57.
21. Ioannides-Demos LL, Christophidis N, Ryan P, et al. Dosing implications of a clinical interaction between grapefruit juice and cyclosporine and metabolite concentrations in patients with autoimmune disease. J Rheumatol 1997;24:49-54.
22. Giorgi M, Meucci V, Vaccaro E, et al. Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4'-hydroxy praziquantel in beagle dogs. Pharmacol Res 2003;47:87-92.
23. He K, Iyer RN, Sinz MW, et al. Inactivation of cytochrome P450 3A4 by bergamottin, a compound of grapefruit juice. Chem Res Toxicol 1998;11:252-259.
24. Plumb DC. Metoclopramide. In: Veterinary drug handbook. 5th ed. Ames, Iowa: Blackwell Publishing, 2005;519-521.
25. Tinker J, Cox AG. Effect of metoclopramide on transport in the small intestine of the dog. Gut 1969;10:986-989.
26. Wadhwa NK, Schroeder TJ, O'Flaherty E, et al. The effect of oral metoclopramide on the absorption of cyclosporine. Transplantation 1987;43:211-213.
27. Desta Z, Wu GM, Morocho AM, et al. The gastrokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P-450 2D6. Drug Metab Dispos 2002;30:336-343.
28. Hanley MJ, Cerundolo R, Radwanski NE, et al. Grapefruit juice, lyophilized grapefruit juice, and powdered whole grapefruit inhibit cytochrome P450-mediated triazolam hydroxylation by Beagle dog liver microsomes. Vet Pharmacol Ther 2010;33:189-195.
29. Greenblatt DJ, von Moltke LL, Harmatz JS, et al. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice. Clin Pharmacol Ther 2003;74:121-129.
30. Korecka M, Solari SG, Shaw LM. Sensitive, high throughput HPLC-MS/MS method with on-line sample clean-up for everolimus measurement. Ther Drug Monit 2006;28:484-490.
31. Johnson BF, Bustrack JA, Urbach DR, et al. Effect of metoclopramide on digoxin absorption from tablets and capsules. Clin Pharmacol Ther 1984;36:724-730.
32. Greiff JM, Rowbotham D. Pharmacokinetic drug interaction with gastromotility modifying agents. Clin Pharmacokinet 1994;27:447-461.
33. TotalPetSupply. Atopica (cyclosporine modified). Available at: www.totalpetsupply.com/index.cfm/fuseaction/product.display/pn/atopica/product_id/9454.htm. Accessed Oct 29, 2009.
34. Solution Health Systems. Grapefruit Solution. Available at: www.vita-health-online.com. Accessed Oct 29, 2009